Across TCGA pan-cancer cohorts, MIR548H4 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR548H4 data layer compared with 1 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR548H4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548H4 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

KIRC, UCEC, and STAD are the cancer types where MIR548H4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
UCEC	DFS	Tertile	All	0.100	0.646	.024	36	view →
STAD	DFS	Tertile	III,IV	0.825	0.327	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR548H4 tumor-vs-normal RNA expression · all MIR548H4 data types